Perceptive Xontogeny Venture Fund II, LP (CIK 1851820) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-23). Recent activity: Buy ATHA (989,270 shares), Buy ATHA (329,756 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Athira Pharma, Inc. (ATHA) | Director | Buy | 989,270 | $6.3M |
| 2025-12-23 | Athira Pharma, Inc. (ATHA) | Director | Buy | 329,756 | $2.1M |
Source: SEC Form 4 filings · as of 2025-12-23